Seroepidemiologic effects of influenza A(H1N1)pdm09 in Australia, New Zealand, and Singapore

Emerging Infectious Diseases

Volumn 19, Issue 1, 2013, Pages 92-101

  Trauer, James M ^a   Bandaranayake, Don ^b   Booy, Robert ^c   Chen, Mark I ^d   Cretikos, Michelle ^d   Dowse, Gary K ^e   Dwyer, Dominic E ^f   Greenberg, Michael E ^g   Huang, Q Sue ^b   Khandaker, Gulam ^c   Kok, Jen ^f   Laurie, Karen L ^h   Lee, Vernon J ^h   McVernon, Jodie ⁱ   Walter, Scott ^j   Markey, Peter G ^k  

^a Melbourne Sleep Disorders Centre   (Australia)

^b INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

^c NATIONAL CENTRE FOR IMMUNISATION RESEARCH AND SURVEILLANCE   (Australia)

^d NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^e UNIVERSITY OF SYDNEY   (Australia)

^f Communicable Disease Control Directorate   (Australia)

^g CSL LIMITED   (Australia)

^h WORLD HEALTH ORGANIZATION   (Switzerland)

ⁱ UNIVERSITY OF MELBOURNE   (Australia)

^j CENTRE FOR EPIDEMIOLOGY AND RESEARCH   (Australia)

^k Centre for Disease Control   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; FEMALE; HEMAGGLUTINATION INHIBITION; HUMAN; INFANT; INFLUENZA A (H1N1); MAJOR CLINICAL STUDY; MALE; NEWBORN; PANDEMIC INFLUENZA; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCHOOL CHILD; SEROEPIDEMIOLOGY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; AUSTRALIA; CHILD; CHILD, PRESCHOOL; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INCIDENCE; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; NEW ZEALAND; OCEANIC ANCESTRY GROUP; PANDEMICS; PREGNANCY; SEROEPIDEMIOLOGIC STUDIES; SINGAPORE;

EID: 84871638797     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1901.111643     Document Type: Article

References (37)

1. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, et al. Emergence of a novel swine-origin influenza A (H1N1) in virus in humans. N Engl J Med. 2009;360:2605-15. http://dx.doi. org/10.1056/NEJMoa0903810
2. Bishop JF, Mumane MP, Owen R. Australia's winter with the 2009 pandemic influenza A (H1N1) virus. N Engl J Med. 2009;361:2591-4. http://dx.doi.org/10.1056/NEJMp0910445
3. Centers for Disease Control and Prevention. Surveillance for the 2009 pandemic influenza A (H1N1) virus and seasonal influenza viruses-New Zealand, 2009. MMWR Morb Mortal Wkly Rep. 2009;58:918-21.
4. Cutter JL, Ang LW, Lai FY, Subramony H, Ma S, James L. Outbreak of pandemic influenza A (H1N1-2009) in Singapore, May to September 2009. Ann Acad Med Singapore. 2010;39:273-82.
5. Barr IG, Cui L, Komadina N, Lee RT, Lin RT, Deng Y, et al. A new pandemic influenza A (H1N1) genetic variant predominated in the winter 2010 influenza season in Australia, New Zealand and Singapore. Euro Surveill. 2010; 15:pii 19692.
6. World Health Organization. Seroepidemiological studies of pandemic influenza A (H1N1) 2009 virus. Wkly Epidemiol Rec. 2010;85:229-35.
7. Booy R, Khandaker G, Heron LG, Yin J, Doyle B, Tudo KK, et al. Cross-reacting antibodies against the pandemic (H1N1) 2009 influenza virus in older Australians. Med J Aust. 2011;194:19-23.
8. Dowse GK, Smith DW, Kelly H, Barr I, Laurie KL, Jones AR, et al. Incidence of pandemic (H1N1) 2009 influenza infection in children and pregnant women during the 2009 influenza season in Western Australia-a seroprevalence study. MedJAust. 2011;194:68-72.
9. Gilbert GL, Cretikos MA, Hueston L, Doukas G, O'Toole B, Dwyer DE, et al. Influenza A(H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter. PLoS ONE. 2010;5:el2562. http:// dx.doi.org/10.1371/journal.pone.0012562
10. Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, Ben-net J, et al. Response to a monovalent 2009 influenza A (HI Nl) vaccine. N Engl J Med. 2009;361:2405-13. http://dx.doi.org/10.1056/ NEJMoa0907413
11. Kok J, Tudo K, Blyth CC, Foo H, Hueston L, Dwyer DE. Pandemic H1N1 (2009) influenza virus seroconversion rates in HIV-infected individuals. J Acquir Immune Defic Syndr. 2011;56:91-4. http:// dx.doi.org/10.1097/QAI.0b013e318204al c3
12. McVemon J, Laurie K, Nolan T, Owen R, Irving D, Capper H, et al. Seroprevalence of 2009 pandemic influenza A (H1N1) virus in Australian blood donors. Euro Surveill. 2010; 15:pii: 19678.
13. Nolan T, McVernon J, Skeljo M, Richmond P, Wadia U, Lambert S, et al. Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in infants and children. JAMA. 2010;303:37-46. http:// dx.doi.org/10.1001 /jama.2009.1911
14. Trauer JM, Laurie K, McDonnell J, Kelso A, Markey PG. Differential impact of pandemic (H1N1) 2009 on remote and indigenous groups in the Northern Territory, Australia. Emerg Infect Dis. 2011;17:1615-23. http://dx.doi.org/10.3201/eidl709.101196
15. Grills N, Piers LS, Barr I, Vaughan LM, Lester R, Magliano DJ, et al. A lower than expected adult Victorian community attack rate for pandemic (H1N1) 2009. Aust N Z J Public Health. 2010;34:228-31. http://dx.doi.Org/10.l 111/j.l 753-6405.2010.00518.x
16. Bandaranayake D, Huang QS, Bissielo A, Wood T, Mackereth G, Baker MG, et al.; 2009 H1N1 Serosurvey Investigation Team. Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. PLoS ONE. 2010;5:el3211. http://dx.doi.org/10.1371/journal.pone.0013211
17. Chen MI, Lee VJ, Lim WY, Barr IG, Lin RT, Koh GC, et al. 2009 influenza A (H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. JAMA. 2010;303:1383-91. http:// dx.doi.org/10.1001 /jama.2010.404
18. Australian Bureau of Statistics. 3201.0 Population by age and sex, Australian states and territories, June 2010 [cited 2011 Apr 3], http:// www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/3201.0Jun%20 2010?0pen Document.
19. Singapore Ministry of Health. Epidemiological News Bulletin April-June 2010 [cited 2011 Jun 13], http://www.moh.gov.sg/ content/dam/mohjweb/Statistics/EpidemiologicalJNews_Bulle-tin/2010/ENB02QJ0.pdf
20. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009;361:1945-52. http://dx.doi. org/10.1056/NEJMoa0906453
21. McCullers JA, Van De Velde LA, Allison KJ, Branumn KC, Webby RJ, Flynn PM. Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus. Clin Infect Dis. 2010;50:1487-92. http://dx.doi. org/10.1086/652441
22. Miller E, Hoschler K, Hardelid P, Standford E, Andrews N, Zam-bon M. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet. 2010;375:1100-8. http://dx.doi.org/l 0.1016/S0140-6736(09)62126-7
23. Wu JT, Ma ES, Lee CK, Chu DK, Ho PL, Shen AL, et al. The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis. 2010;51:1184-91. http://dx.doi. org/10.1086/656740
24. Tandale BV, Pawar SD, Gurav YK, Chadha MS, Koratkar SS, Shel-ke VN, et al. Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India. BMC Infect Dis. 2010;10:255. http://dx.doi.org/l 0.1186/1471-2334-10-255
25. Lowen AC, Steel J, Mubareka S, Palese P. High temperature (30°C) blocks aerosol but not contact transmission of influenza virus. J Virol. 2008;82:5650-2. http://dx.doi.Org/10.l 128/JVI.00325-08
26. Beard JA, Bearden A, Striker R. Vitamin D and the anti-viral state. J Clin Virol. 2011;50:194-200. http://dx.doi.Org/10.1016/j. jcv.2010.12.006
27. Falagas ME, Koletsi PK, Baskouta E, Rafailidis PI, Dimopoulos G, Karageorgopoulos DE, et al. H1N1 2009 influenza: review of the Southern Hemisphere experience. Epidemiol Infect. 2011; 139:27-40. http://dx.doi.org/l0.1017/S0950268810002037
28. Riera M, Payeras A, Marcos MA, Viasus D, Farinas MC, Segura F, et al. Clinical presentation and prognosis of the 2009 H1N1 influenza A infection in HIV-l-infected patients: a Spanish multicentre study. AIDS. 2010;24:2461-7. http://dx.doi.org/10.1097/ QAD.0b013e32833e508f
29. Gordon CL, Johnson PD, Permezel M, Holmes NE, Gutteridge G, McDonald CF, et al. Association between severe pandemic 2009 influenza A (HI Nl) virus infection and immunoglobulin G(2) subclass deficiency. Clin Infect Dis. 2010;50:672-8.
30. Kelly H, Mercer G, Cheng A. Quantifying the risk of pandemic influenza in pregnancy and indigenous people in Australia in 2009. Euro Surveill. 2009; 14:pii 19441.
31. Aho M, Lyytikaïnen O, Nyholm JE, Kuitunen T, Rönkkö E, San-tanen R, et al. Outbreak of 2009 pandemic influenza A(H1N1) in a Finnish garrison-a serological survey. Euro Surveill. 2010; 15:pii: 19709.
32. Kelly H, Riddell MA, Gidding HF, Nolan T, Gilbert GL. A random cluster survey and a convenience sample give comparable estimates of immunity to vaccine preventable diseases in children of school age in Victoria, Australia. Vaccine. 2002;20:3130-6. http://dx.doi. org/10.1016/S0264-410X(02)00255-4
33. Australian Government Department of Health and Ageing. Review of Australia's health sector response to pandemic (H1N1) 2009: lessons identified [cited 2012 Jul 5], http://www.flupandemic.gov. au/ intemet/panflu/publishing.nsf/Content/review-201 l/$File/les-sons%20identified-octl 1.pdf.
34. Paine S, Mercer GN, Kelly PM, Bandaranayake D, Baker MG, Huang QS, et al. Transmissibility of 2009 pandemic influenza A(H1N1) in New Zealand: effective reproductive number and influence of age, ethnicity and importations. Euro Surveill. 2010;15:pii:19591.
35. Tay J, Ng YF, Cutter JL. James L. Influenza A (H1N1-2009) pandemic in Singapore-public health control measures implemented and lessons learnt. Ann Acad Med Singapore. 2010;39:313-24.
36. Kok J, Dwyer DE. How common was 2009 pandemic influenza A H1N1 infection? Lancet Infect Dis. 2011;11:423-4. http://dx.doi. org/10.1016/S 1473-3099(11)70120-7
37. Chen MI, Barr IG, Koh GC, Lee VJ, Lee CP, Shaw R, et al. Serological response in RT-PCR confirmed H1N1-2009 influenza a by hemagglutination inhibition and virus neutralisation assays: an observational study. PLoS ONE. 2010;5:el2474. http://dx.doi.org/10.1371/ joumal.pone.0012474